Aims and Objectives: This is to determine the age range of the lesion within our study;as a way to suggest possible recommendation (s 
I.
Introduction:
Benign Prostatic hyperplasia (BPH) is usually a common disorder in most men over age of 50 years and is characterized by prostatic hyperplasia of the stromal components and epithelial cells. These results to formation of large,fairly discrete nodules in the peri-urethral region of the prostrate. These nodules grows to compress and narrow the urethral canal causing partial or at times complete obstruction of urether. 1 Histologic evidence of BPH could be seen with aging: as prevalence varies from 20-25% among men of 40 to 49 years of age. 1, 2 This is increases to 80% among 70-79years of age. 2 Many men with histologic findings of BPH and anatomically enlarged prostrate have no symptoms; but more than 50%-70% of men are in 60s and 90% are octogenarians. The later presenting with lower urinary tract symptoms with lower urinary symptoms. 3 However, in USA, about 14 million men has lesion of BPH;as this increases with age. It is observed that 25% of men older than 40 years has such symptoms of BPH. This increases to 1/3 of men older than 65 years. 4 This prevalence increases from moderate to severe symptoms from 13% in men in their 40s to 28% in older than 70 years of age. 3 In Berry SJ et al studies -they observed that prevalence of pathological BPH occurs at 8 % in 4 th decade; but 50% of male population has pathological BPH when they are 51-60 years old. They average weight of the prostrate seen at autopsy is 33 plus or minus 16gm;about 4% at age greater than 70 years old reaches greater than more than 100gm. These shows that BPH growth in men 31 and 50 years old doubles by 4.5years and mid-phase growth at 51 and 70 years doubling is in about 10 years as this increases greater than 100 years beyond 70 years old. 2 Other etiological factors have been associated with BPH apart from older age and normal androgenic function with a prostrate family history. Factors like race, geographic location, cigarette smoking and male pattern of baldness have also been implicated. 5, 6 Similar report by steve A. Kaplan showed that a few things may cause lower urinary tract symptoms which could be urologic and non urologic states; mediators that increases obstructive urinary symptoms, obesity, regular alcohol consumption, and elevated blood pressure all could lead to benign prostatic hyperplasia. 7, 8 This is supported too in Aruna v. sarma et al studies were they alluded that black 9 , obesity 10 ,diabetes mellitus 11 ,high levels of alcohol consumption 12 and physical inactivity 13 increases risk of BPH development. The obstructive symptoms includes the urinary hesistancy, delay in initiating micturition, intermittency, involuntary interruption of voiding, weak urinary stream, straining to void, a sensation of incomplete emptying, and terminal dribbling. The irritating or storage symptoms on the other hand are urinary frequency, nocturia, urgency, incontinence and bladder pain or dysuria.
However, prostatic hypertrophy process involves all four cell types namely smooth muscle cells, fibroblast, acinar and basal epithelium with some hormones like growth factors and receptors.
14 These affirms that BPH is an endocrine disease. In matured male, testicular androgens is said to regulate growth, development and functional maintenance of the prostratic glands. Also androgens tends to regulate (PSA) prostatic specific antigen secretion by epithelial acinar cells. This PSA a serine protease derivatives is produced by benign and malignant prostatic epithelium, as is a marker for BPH and cancer of prostrate. This is often seen in benign inflammatory disorders of prostrate. 15 The pathophysiology of this hyperplasia is dependent on the bioavailability of testosterone and its metabolite, dihydrotesterone 16 . Also congenital deficiency of 5 alpha reductase will lead to vestigial prostatic gland 17 and castration consequently resulting to glandular atrophy/lower urinary tract symptoms regression. 18 Other factors like high levels of dehydroepiandrosterone, estradiol and insulin-like growth factors are risk factors for formation of BPH. 19, 20 Finally, is well known that bladder dysfunction plays a role in some, if not most of the BPH -related signs and symptoms as that have suggested the use pharmacopies that stimulates the bladder example antimuscuranics with calcium antagonistic may improve storage urinary symptoms. Recently, use of alpha blocker and antimuscuranic agents is now used once bladder outlet is related to BPH and co-exist with overactive bladder symptoms. Hence, combination treatment to decrease resistance to urine outflow through prostatic urethra and increase bladder smooth muscle may assist in bladder outlet surgery success and in detrusor hypocontractility.
II. Materials and Method:
A cross sectional study of all histologically 463 diagnosed sample of prostrate sent and reported as benign prostatic hyperplasia were retrieved from the dept. report register from January 2005 to December 2012. They were analyzed using SPSS version 16 while considering the age range, number of occurrence/percentages on each year respectively.
III.
Results: It showed the most vulnerable age of the lesion to be 50-60 years in all the years of study. As this is the commonest age range that had benign prostatic hyperplasia within the seven years of study. This is closely followed by 60 -70 years. The least being above 70 years. However, it is significant to note that a few are of no age/specificity in almost all the years of study. As they appear as inscription of adult at age column which does not place them within any age range of the study.
IV. Discussion/Conclusion:
It is well known that the age range of 50-60 years appears to be the more vulnerable in all the years of the study when most patients had benign prostatic hyperplasia. Above 60 years we still had the lesions recorded and at greater than 70 years a few were seen. This is also same experience in most studies as is known that age is an important risk factor in urinary retention with consequent gradual enlargement of the prostrate. Roehrborn C.G et al 21 found that men diagnosed with BPH,urinary retention (UR) risk increases with aging as 1 in 10 at age of 70s will experience urinary retention within the next 5 years. This increases to 1 in 3 for men in 80s. Its generally believed that higher rates of UR in older men is due to weakening detrusor functions. 22 This is also supported by Steve A. Kaplan who said that prostatic enlargement is more commoner as men ages; and more than half in men aged 50 and 60 years. However, these patients are often seen because of lower urinary tract symptoms or by digital examination showing enlarged prostrate or by elevated PSA as a routine examination. 23 Carl K. Gjertson et al also affirmed that prevalence of BPH increases with age as 25 % of men older than 40 years experience BPH symptoms and this increases about 1/3 of men older than 65 years. 24 These gets from moderate to severe symptoms from 13% greater in men of 40s to 28% older than 70years of age. 24 Finally, a better understanding of all risk factors and rates of clinical progression of BPH helps in medical therapy of patients. Since urinary retention is one of the most usual and significant complications of long term benign prostrate hyperplasia; as risk is cumulative with increasing age which calls for both conservative and surgical therapy.
